AbbVie

Tolero Pharmaceuticals and AbbVie partner to develop AML therapy

Biopharmaceutical firm Tolero Pharmaceuticals and AbbVie have formed a clinical research alliance to evaluate venetoclax and alvocidib combination for relapsed…

AbbVie signs patent licensing deal with Mylan over Humira biosimilar

AbbVie has entered patent licence agreements with Mylan for the proposed biosimilar product of its Humira (adalimumab) drug. Adalimumab is…

AbbVie submits venetoclax sNDA for acute myeloid leukaemia

AbbVie has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the use…